Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia I Murali, S Kasar, A Naeem, S Tyekucheva, JK Khalsa, EM Thrash, ... Blood, The Journal of the American Society of Hematology 138 (1), 44-56, 2021 | 40 | 2021 |
Activating MAPK pathway mutations mediate primary resistance to PI3K inhibitors in chronic lymphocytic leukemia (CLL) I Murali, S Kasar, EM McWilliams, G Itchaki, S Tyekucheva, D Livitz, ... Blood 132, 587, 2018 | 19 | 2018 |
pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with … HN Madhavan, MY Samson, M Ishwarya, R Vijayakumar, M Jambulingam Virology Journal 7, 1-7, 2010 | 15 | 2010 |
The effect of chronic alcohol consumption on mitochondrial calcium handling in hepatocytes G Wang, E Mémin, I Murali, LD Gaspers Biochemical Journal 473 (21), 3903-3921, 2016 | 13 | 2016 |
Functional testing to characterize and stratify PI3K inhibitor responses in chronic lymphocytic leukemia Y Yin, P Athanasiadis, L Karlsen, A Urban, H Xu, I Murali, SM Fernandes, ... Clinical Cancer Research 28 (20), 4444-4455, 2022 | 8 | 2022 |
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples JK Khalsa, J Cha, F Utro, A Naeem, I Murali, Y Kuang, K Vasquez, L Li, ... Blood 142 (5), 421-433, 2023 | 7 | 2023 |
Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia Y Yin, P Athanasiadis, L Karlsen, A Urban, I Murali, SM Fernandes, ... BioRxiv, 2022.04. 14.488428, 2022 | 2 | 2022 |
Functional characterization of novel mutations in UL54 of ganciclovir resistant HCMV strain using structural analysis J Malathi, V Umashankar, R Sathyabaarathi, S Muthukumaran, ... Bioinformation 5 (9), 390, 2011 | 2 | 2011 |
Potential Drivers of Acquired Resistance to Idelalisib in CLL Patients S Yadav, J Khalsa, I Murali, RR Furman, NE Kay, E Braggio, JR Brown Blood 140 (Supplement 1), 12373-12374, 2022 | 1 | 2022 |
P626: FUNCTIONAL SCREENING OF PI3K INHIBITORS STRATIFIES RESPONDERS TO IDELALISIB AND INDICATES DRUG CLASS ACTIVITY IN IDELALISIB-REFRACTORY CLL S Skånland, Y Yanping, P Athanasiadis, L Karlsen, A Urban, I Murali, ... HemaSphere 6, 525-526, 2022 | | 2022 |
Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL) I Murali, J Cha, I Leshchiner, Y Kuang, K Vasquez, J Khalsa, ... Cancer Research 81 (13_Supplement), 1097-1097, 2021 | | 2021 |
ALCOHOL-ASSOCIATED PERTURBATION IN CYTOSOLIC CALCIUM SIGNALING AND MITOCHONDRIAL CALCIUM HANDLING PJ Bartlett, G Wang, AN Antony, E Memin, I Murali, JB Hoek, LD Gaspers ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 41, 271A-271A, 2017 | | 2017 |
Role of Calcium in Nutrient Stimulation of MTORC1 I Murali Rutgers University, Graduate School of Biomedical Sciences, 2017 | | 2017 |